Related Experiment Videos
Increased risk of death from primary hyperparathyroidism--an update
1Department of Surgery, Sahlgrenska Hospital, Gothenburg, Sweden. tomashe@tripnet.se
European Journal of Clinical Investigation
|June 6, 1998
Summary
Patients treated for primary hyperparathyroidism face an increased risk of death, particularly from cardiovascular disease. This highlights the importance of understanding long-term outcomes for this condition.
Area of Science:
- Endocrinology
- Cardiovascular Health
- Public Health
Background:
- Primary hyperparathyroidism is a condition affecting calcium regulation.
- Long-term mortality risks associated with primary hyperparathyroidism require further investigation.
Purpose of the Study:
- To assess the mortality risk in patients treated for primary hyperparathyroidism.
- To identify specific causes of death and associated risk factors in this patient group.
Main Methods:
- Utilized Swedish national patient and death registers (1987-1994).
- Included 4461 patients operated on for primary hyperparathyroidism.
- Matched controls from the general Swedish population by age, sex, and calendar year.
Main Results:
- Patients with primary hyperparathyroidism exhibited an elevated risk of death.
- Cardiovascular disease mortality risk ratios were 1.71 for males and 1.85 for females.
- High precision estimates were obtained due to the large sample size.
Conclusions:
- Treatment for primary hyperparathyroidism is associated with increased mortality.
- Factors like parathyroid adenoma weight and serum calcium/parathyroid hormone levels predict mortality risk.
- Surgery may improve prognosis beyond symptom relief for primary hyperparathyroidism patients.